Here is a list of stocks with an above 10% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. United Community Banks, Inc.
21.2% sales growth and 8.6% return on equity
United Community Banks, Inc. sales growth this year is expected to be 16.4% and 1.7% for next year.
Year-on-year quarterly revenue growth grew by 6.7%, now sitting on 533.87M for the twelve trailing months.
United Community Banks, Inc.'s sales growth for the next quarter is 21.2%. The company's growth estimates for the present quarter and the next is a negative 4.9% and 34.1%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 8.6%.
United Community Banks, Inc.'s Stock Top and Bottom Yearly Value
United Community Banks, Inc.'s stock is valued at $0.00 at 10:57 EST, below its 52-week low of $14.95.
United Community Banks, Inc.'s Moving Average
United Community Banks, Inc.'s value is under its 50-day moving average of $24.20 and under its 200-day moving average of $20.01.2. First Foundation Inc.
14.2% sales growth and 12.04% return on equity
First Foundation Inc. sales growth this year is expected to be 17.5% and 2.4% for next year.
Year-on-year quarterly revenue growth grew by 29.4%, now sitting on 234.63M for the twelve trailing months.
First Foundation Inc.'s sales growth for the next quarter is 14.2%. The company's growth estimates for the present quarter and the next is 29.4% and 41.4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.04%.
First Foundation Inc.'s Stock Top and Bottom Yearly Value
First Foundation Inc.'s stock is valued at $18.85 at 10:57 EST, below its 52-week high of $20.24 and way higher than its 52-week low of $8.01.
First Foundation Inc.'s Moving Average
First Foundation Inc.'s value is above its 50-day moving average of $17.23 and way higher than its 200-day moving average of $15.65.3. Capital City Bank Group
28.1% sales growth and 12.48% return on equity
Capital City Bank Group sales growth this year is anticipated to be 36.3% and a negative 2.3% for next year.
Year-on-year quarterly revenue growth grew by 49.5%, now sitting on 188.94M for the twelve trailing months.
Capital City Bank Group's sales growth for the next quarter is 28.1%. The company's growth estimates for the current quarter and the next is a negative 2% and 76%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.48%.
Capital City Bank Group's Stock Top and Bottom Yearly Value
Capital City Bank Group's stock is valued at $25.55 at 10:57 EST, way below its 52-week high of $30.95 and way higher than its 52-week low of $15.61.
Capital City Bank Group's Moving Average
Capital City Bank Group's worth is way above its 50-day moving average of $23.16 and way above its 200-day moving average of $20.82.4. BioDelivery Sciences International, Inc.
14.1% sales growth and 18.1% return on equity
BioDelivery Sciences International, Inc. sales growth this year is expected to be 37.3% and 27.7% for next year.
Year-on-year quarterly revenue growth grew by 30.1%, now sitting on 145.94M for the twelve trailing months.
BioDelivery Sciences International, Inc.'s sales growth for the next quarter is 14.1%. The company's growth estimates for the present quarter and the next is 700% and 100%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 18.1%.
BioDelivery Sciences International, Inc.'s Stock Top and Bottom Yearly Value
BioDelivery Sciences International, Inc.'s stock is valued at $4.31 at 10:57 EST, way under its 52-week high of $7.21 and way above its 52-week low of $2.85.